This trial is conducted in Europe. The aim of this trial is to compare two formulations of insulin detemir containing an isotonic agent in healthy volunteers.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Enrollment
34
Single dose containing mannitol as isotonic agent. Administered subcutaneously (s.c., under the skin)
Single dose containing glycerol as isotonic agent. Administered subcutaneously (s.c., under the skin)
Unnamed facility
Manchester, United Kingdom
Area under the serum insulin detemir concentration curve
Maximum serum insulin concentration
Area under the glucose infusion rate curve
Time to maximum serum insulin concentration
Terminal serum insulin half life
Area under the serum insulin detemir concentration curve
Maximum glucose infusion rate
Time to maximum glucose infusion rate
Adverse events
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.